{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-112912","form_type":"8-K","ticker":"FENC","cik":"0001211583","company_name":"FENNEC PHARMACEUTICALS INC.","filed_at":"2025-11-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.952479+00:00","generated_at":"2026-05-16T19:07:47.222765+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Fennec prices $35M public offering of 4.7M shares at $7.50/share to repay debt","bullets":["Offering of 4,666,667 common shares at $7.50 per share; gross proceeds ~$35M.","Underwriters granted 30-day option to purchase up to 700,000 additional shares.","Net proceeds to repurchase and redeem certain indebtedness and for working capital.","Closing expected November 17, 2025, subject to customary conditions.","Joint book-running managers: Piper Sandler & Co. and Craig-Hallum Capital Group."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-112912","json":"https://secwatch.observer/filing/0001104659-25-112912.json","markdown":"https://secwatch.observer/filing/0001104659-25-112912.md","text":"https://secwatch.observer/filing/0001104659-25-112912.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1211583/000110465925112912/0001104659-25-112912-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1211583/000110465925112912/tm2531308d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T19:07:47.222765+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}